CEVA Animal Health has launched the anti-inflammatory Meloxidyl for cattle and pigs.
Meloxidyl is meloxicam-based solution for the management of respiratory disease, mastitis and diarrhoea in cattle and non-infectious locomotor disorders and puerperal septicaemia and toxaemia in pigs. It is given via a single injection, when used in combination with suitable anti-infectives.
According to the company, Meloxidyl's one shot protocol means it is quick and economical to use; it allows control of inflammation and endotoxins and reduces somatic cell count, recovery time and risk of culling after clinical mastitis; it reduces the economical impact of respiratory signs in comparison with flunixin-based products and reduces the major clinical signs caused by toxins in cases of neonatal diarrhoea.
Meloxidyl can be used in combination with the company's range of anti-infectives, which includes Marbokem, Cevaxel and Florkem.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
A new infographic and educational webinar are now available to share on social media, to increase farmer awareness and provide best practice guidance.
The infographic and webinar explain how vaccination is considered best practice for control of the disease, giving better disease control whilst ensuring responsible use of antibiotics.
Independent sheep veterinary consultant Dr Fiona Lovatt, who leads the cross-industry Sheep Antibiotic Guardian Group, said: "Despite EAE being responsible for over 35% of all abortion diagnoses, only one million of the 3.5 million replacement ewes in the national flock each year are vaccinated against EAE. Any sheep farmer that either buys in ewes for replacements or has close neighbours that also lamb sheep, risks bringing enzootic abortion into their flock.
"Once the disease infects an unvaccinated flock, some ewes are ‘programmed’ to abort at their next lambing, leaving no choice but to put remedial measures in place – usually including both vaccination and antibiotic treatment.
"This means EAE is a disease that, once in a flock, carries high costs both financially and emotionally in terms of lamb losses and farmer stress. Hence it is important that flocks receive appropriate vaccination at least four weeks before ewes go to the ram and avoid the inappropriate use of antibiotics closer to lambing."
Fiona points out that a single dose of EAE vaccine costs about £2.40 and is an investment that effectively lasts the ewe for her lifetime in the flock, protecting against losses. In contrast, abortion or stillbirth – which accounts for around a quarter of all lamb losses each year – costs over £25 for every single lost lamb.
Fiona added: "Every injection of antibiotics also costs an additional £1. But is just a ‘sticking plaster’ with short-lasting effectiveness in terms of disease control but long-lasting damage in terms of mounting resistance."
Ceva says it will continue to work closely with veterinary practices to secure stock of Cevac Chlamydia vaccine to ensure farmers can purchase and use the vaccine at the right time. Ceva also provides subsidised blood sampling for diagnostic purposes.
For further information, call Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.
Photo: Mike Benjamin
MSD Animal Health has announced a new claim for Bovilis BVD and Bovilis IBR Marker Live vaccines which means they can be mixed and administered in a single syringe.
MSD says the new mixing claim will offer significant advantages in herd health planning when controlling two of the more important infectious diseases in cattle.
Bovine Viral Diarrhoea (BVD) and Infectious Bovine Rhinotracheitis (IBR) remain major threats to cattle health and productivity. Vaccinations are commonly given at housing and/or turnout, which are both busy times for veterinary surgeons and on the farm in the herd health planning calendar.
The mixed vaccines are suitable only for booster vaccinations of animals from 15 months of age previously vaccinated separately with Bovilis IBR Marker Live and Bovilis BVD. The mixed vaccine needs to be used within three hours.
MSD says the mixing procedure is clear and easy, but there is an instructional video here: http://www.msd-animal-health.co.uk/Mixing_bovilis_BVD_Bovilis_IBR-Marker_Live.aspx
Tom graduated from the Royal Veterinary College (RVC) in 2017 and joined Synergy Farm Health full-time in 2018, after completing his postgraduate diploma (PGDipVCP) with the RVC.
Nominated by his practice, Tom is described as a fine example of a dedicated caring professional who is passionate about sustainability, has a keen sense of his clients’ needs, and has developed strong working relationships with the farms under his care.
The judging panel found that Tom uses data effectively in herd health planning to highlight areas of improvement, working in partnership with his clients to promote disease prevention and profitability.
Tom’s clients spoke of his knowledge and caring attitude and how much he is valued as part of their team.
Tom said: “It was a privilege to be a part of the awards and to see farmers and businesses acknowledged - farmers don’t always get the recognition they deserve and seeing British dairying showcased was amazing.
"I hope winning is reward for the time and effort colleagues at Synergy put into young vets too, and that I can put it to good use supporting clients and working with other organisations within the dairy industry.
"My aim as a vet has been simply to support clients the best I could, both clinically and emotionally, so to have won made it a fantastic night and one I won’t be forgetting!”
The runner up as Charlie Mays of LLM Vets, who the judging panel praised for making effective changes on farm towards preventive healthcare and using data to assist with health and profitability.
Charlie also lobbies government to support the interests of the farmer and the industry.
Sabrina Jordan from Virbac said: ‘Virbac has been supporting dairy vets with products and services for over 50 years and recognise the commitment of young dairy vets to the profession.
"The standard of nominations into this category was outstanding, and our winner and highly commended nominees are a true credit to the veterinary profession, both are shining lights of the future’.
CEVA Animal Health has now introduced Colibird, the UK's first colistin-based soluble antimicrobial approved for poultry.
According to the company, colistin is an important active in the UK's antimicrobial armoury, with a potent bactericidal action against Gram-negative bacteria, including enterobacteria and more particularly E. coli. Colibird is only one of a handful of products approved for layers that has a zero egg withhold. It also has almost zero levels of resistance, even with bugs variously resistant to other antimicrobials and is easily and efficiently administered in drinking water via header tanks or dosing pumps.
For further information please contact the large animal sales team or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
The Farm Animal Welfare Council (FAWC) has launched its "Report on the implications of castration and tail docking for the welfare of lambs".
The report considers the implications of castration and tail docking for the welfare of lambs and reiterates FAWC's earlier view that castration and tail docking of lambs are mutilations which should not be undertaken without strong justification.
Professor Wathes, Chairman of FAWC, said: "FAWC believes that scientifically based advice can now be given that will minimise the suffering arising from castration and tail docking."
He continued "If castration is warranted, some methods cause more suffering than others and pain relief should be given once practical methods of delivering local anaesthetics and analgesics have been developed."
The full report is available for download at: http://www.fawc.org.uk/
The first, 'Factors that determine the success of a mastitis treatment' is tomorrow, Thursday 30th April, at 7:30pm. It will be presented by veterinary surgeon and researcher, Sofie Piepers.
The second webinar is titled 'Communication skills for effecting behaviour change with a focus on mastitis treatments'. Presented by Owen Atkinson, a vet with experience of the dairy industry around the world, the webinar will start at 7:30pm on Tuesday 5th May.
There will be opportunities to ask questions of both speakers at the end of each session.
For more information, visit: https://www.boehringer-academy.co.uk
The vaccine has been developed from Suvaxyn Circo+MH RTU, and also contains MetaStim as adjuvant 1.
MetaStim is an emulsion containing a metabolisable (non-mineral) oil and is used in vaccines to help elicit both humoral and a cell-mediated immune responses. Zoetis says it is thought to preserve the vaccine components so the antigens are released slowly as compared to other types of adjuvants2.
Alvaro Aldaz, Director Commercial Development and Innovation, Swine, Zoetis, said: "The safety and efficacy of MetaStim has been well documented given its use in several swine, cattle and equine vaccines for the past several years.
"In fact, the MetaStim adjuvant is currently used in our bivalent vaccine – Suvaxyn Circo+MH RTU. Suvaxyn Circo is the monovalent PCV2 fraction of the parent vaccine and it delivers a similar performance profile for PCV2 protection."
More than 250 million pigs are vaccinated against Circovirus every year in Europe.
Professor Hans Nauwynck, Director of the Laboratory of Virology at Ghent University said: "Vaccination of piglets against Circovirus has become a standard in pig farms across Europe.
"The goal is achieving strong immunity, both cell mediated and antibodies, against a virus that is always in the farm.
"Veterinarians should consider several factors when deciding the best timing for vaccination, being especially important the levels of maternal immunity in the pigs to be vaccinated, the presence of co-infections like PRRSV and the expected infection pattern in the farm."
Suvaxyn Circo is a new tool for veterinarians and producers who prefer monovalent vaccines. In situations where early vaccination of piglets against M.hyo is preferred, for example using Suvaxyn MH-One which is licensed for administration from one week of age, there will be a need to give a separate monovalent vaccine to cover PCV2. In such cases, Suvaxyn Circo from three weeks of age can be considered as an option.
Suvaxyn Circo is available in 50- and 125-dose vials.
For more information, contact your Zoetis representative.
References
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
SMITHS Detection, part of the global technology business Smiths Group, today announces it is to launch a portable detection system that will enable veterinarians to carry out on-site diagnosis of animal diseases such as foot-and-mouth and avian flu.
This new technology means vets will be able to diagnose diseases in livestock and birds in the field in less than 90 minutes rather than having to send samples for laboratory analysis.
The new system will be launched to vets at the World Association of Veterinary Laboratory Diagnosticians conference in Australia in November 2007 and is expected to be in production in mid 2008.
Veteran campaigner and RCVS Councillor Danny Chambers MRCVS (pictured right) has started a petition to George Eustice on change.org that: Future trade deals must not compromise animal welfare and public health.
The petition has gathered an impressive 21,984 signatures, of which Danny says that more than 500 are from veterinary surgeons.
Meanwhile VetPartners is calling on the retail and food service sector to give priority to British produce, even if future trade deals enable the import of foods produced to lower standards.
Ian Cure, farm director at VetPartners, is contacting the UK’s main retailers to discuss how they can support British farmers in the months and years to come. He has the backing of the clinical directors at each of the 28 farm or mixed practices within the group, which collectively look after the health and welfare of over 30% of the UK’s dairy population and 45% of the pig population.
“We are asking retailers to prioritise a range of Red Tractor certified produce at varying prices, while avoiding designating shelf space to imports of a lower quality. Likewise, the food service sector can choose to source from UK food supply chains.
“These sectors have a high level of influence, as consumers will pick from what is clearly available, which is why we see it as the best way to support our farmers.
“We are incredibly concerned about how the higher welfare and production standards in UK agriculture will be protected long term, given that MPs failed to enshrine that protection in law when voting against the recent amendment to the Agriculture Bill last month.
“Future trade deals to allow the import of cheap food from countries outside of the EU would be a step in the wrong direction, as our farmers will not be competing on an even playing field as they attempt to compete with countries with lower costs of production.”
However, Ian adds that this is not just a welfare issue: "If the UK livestock sector is forced to adopt practices that are frowned upon in Europe to compete, such as the American applications of hormone growth treatments and chlorinated chicken, we would be severely risking our local, lucrative European export market.
“While trade with countries such as the USA and Australia may have benefits from an economical perspective, the carbon emissions associated with longer distance transport of food is a real concern.
“We see it as imperative that higher welfare standards are maintained, while reducing the carbon footprint of our food supply – it's the right, sustainable thing to do. As MPs have let down the sector, we are now calling on retailers and the food service industry to back UK farming."
Veterinary practices are being encouraged to enter the annual Veterinary Marketing Association's (VMA) awards, which now include a practice-only category.
The annual VMA awards are intended to recognise excellence in all aspects of veterinary and animal health marketing. The Practice Marketing Award, sponsored by Pfizer, is awarded to the companion or production animal practice that demonstrates the most initiative and innovation in the marketing of its products and/or services to end users. This can involve the use of any form of activity, including advertising, websites, direct mail and media relations.
Last year's winner of this award was Kessock Equine Vets from Aberdeen, who travelled down to London to receive their award at a presentation lunch. The 2009 awards presentation ceremony takes place on Friday, 19th March at the Old Brewery in Chiswell Street, London. The meeting also presents a very good opportunity for vets to meet representatives from all the major animal health companies.
Tickets for the event cost £115+VAT for VMA/VMPA members (£150+VAT for non-members). The price includes a three-course meal (prepared by a two-star Michelin chef) with wine, a champagne reception and entertainment by a top comedian.
Further information on the awards is available on the Veterinary Marketing Association's website - http://www.vma.org.uk/. Closing date for entries is 5th February 2010.
BVA President Harvey Locke used his annual London dinner speech last night to urge the Government to take action on veterinary student fees and the welfare of dogs, and respond to the consultation on dangerous dogs.
Guests at the dinner included The Rt Hon Caroline Spelman MP, Secretary of State for Defra, parliamentarians, veterinary surgeons, and representatives from the agri-food industry, pet industry, welfare charities, research and veterinary education.
Mr Locke began by raising concerns over cuts to animal health and welfare and disease surveillance budgets: "In the Comprehensive Spending Review Defra took one of the biggest hits. The profession remains deeply concerned that cuts in research and development and disease surveillance could have catastrophic consequences. Right now the UK enjoys some of the highest animal health and welfare standards in the world and so it is in all of our interests to ensure the viability of the farming sector amidst massive competition from abroad, where those standards may not always be as high."
On veterinary student fees, Mr Locke outlined the 'double whammy' of a long course and compulsory Extra Mural Studies in the holidays: "Our role as the guardians of animal health and welfare faces an uncertain future following the announcement that the cap on tuition fees will be raised to between 6 and 9 thousand pounds a year. We fear this could have a huge impact on the decisions of A-level students, with fewer and fewer opting for an expensive veterinary science degree.
"Although the plans are not yet finalised we are bracing ourselves for veterinary degrees, which are costly to run, to be priced at the top of the scale, meaning veterinary students of the future will graduate with at least £45,000 of debt in tuition fees alone. Faced with these levels of debt, our concern is that those who do make it to graduation won't opt for the food animal practice and public health roles that attract smaller pay packages. We need to think carefully about how we can secure the future provision of large animal practitioners."
On companion animal issues Mr Locke asked Defra not to defer all decisions on dog welfare to the newly-formed Dog Advisory Council: "While the BVA fully supports the Advisory Council, we would urge the Government not to use it to delay decisions that might improve the health and welfare of dogs now. At a recent meeting of the Associate Parliamentary Group on Animal Welfare (APGAW) ...there was overwhelming support for provision for healthy breeding to be brought into Defra's welfare codes.
"We have long maintained that to ignore breeding in the dog welfare code is a serious oversight by Defra. In England we already have regulations that protect our farmed animals from breeding procedures that cause suffering or injury, but not for our pets. This contradictory approach makes little sense. Updating the welfare codes to include breeding would send a clear message that the Government is committed to improving the health and welfare of man's best friend."
On dangerous dogs Mr Locke renewed the BVA's call for the Government to respond to the Defra consultation, which found 77% in favour of scrapping breed-specific legislation: "Despite this overwhelming call from the public, the Government has kept its powder dry, repeatedly promising to announce its response soon.
"Secretary of State I would like to assure you that the BVA is prepared to work with all of the other organisations with an interest in dog welfare and public safety to find an effective solution. We all want to see people protected on private property; legislation that targets irresponsible owners and not just the way a dog looks; and tools that allow the police and other enforcement agencies to act swiftly to protect the public.
"And, crucially, we all want to work with you to achieve these aims."
Novartis Animal Health has announced the launch of Strenzen, an oral water medication for pigs, indicated for the treatment of gastrointestinal infections caused by Escherichia coli, Clostridium perfringens and Salmonella Typhimurium, and for respiratory tract infections caused by Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Strenzen contains contains a combination of amoxicillin trihydrate (500 mg/g) and potassium clavulanate (125 mg/g) in ratio of 4:1. Novartis says it is ideally suited for the treatment of post-weaning infections in pigs.
According to the company, the combination of amoxicillin and clavulanic acid broadens the performance of amoxicillin1,2, especially against resistant strains of bacteria capable of producing ß-lactamase enzymes. Certain bacteria are able to produce ß-lactamase enzymes as a protection mechanism, making the amoxicillin molecule ineffective against them. The clavulanic acid in Strenzen binds to the molecules of the ß-lactamase enzyme, ensuring the amoxicillin remains unaffected and free to attack bacteria. Prof. Dominiek Maes, DVM, MSc, MS, PhD, Dipl. ECVPH, Dipl. ECPHM, from the Porcine Health Management Unit of the Ghent University, Belgium said: "Weaning is a stressful event for piglets and there are several opportunistic diseases that can impact them during this period. The challenge with E. coli and S. suis infections is that in many countries there are currently no commercial vaccines available with proper efficacy. I believe Strenzen can indeed be very helpful in managing those infections which are so prevalent after weaning."
Novartis says Strenzen is rapidly excreted, leading to a withdrawal period of one day, which in turn maximizes production flexibility for pig producers. In addition, the water-soluble formulation of Strenzen ensures that treated pigs get a therapeutic dose even when they stop eating, making it an ideal treatment for sick pigs with compromised appetites.
Recent field trials on infected farms in Spain and the Czech Republic demonstrated that Strenzen-treated pigs give better production performance, better economic returns and require less medical intervention3,4,5. The reduction of the overall amount of antibiotics needed to treat severe post-weaning infections not only saves producers the costs of the labour and the medication, but is also important in regard to the development of resistance in bacteria.
Dr. Ulrich Klein, Global Technical Services Manager, Novartis Animal Health said: "With the launch of Strenzen, Novartis Animal Health demonstrates its commitment to continually broadening our product portfolio to address the specific needs of farmers and food producers. Strenzen has the ideal spectrum for the treatment of post-weaning infections, delivering better productivity results than current therapies for those infections."
Vetoquinol UK has launched Marbocyl Solo – a one shot treatment for Bovine Respiratory Disease. Marbocyl Solo is a 100mg/ml solution of marbofloxacin given as one injection IM at 8mg/kg. It treats sick animals fast, killing bacteria in one go, therefore minimising lung damage and consequential morbidity. This fast action reduces the risk of the spread of infection. On top of that, Marbocyl Solo has a meat withdrawal of only 3 days (milk 3 days). “Marbocyl is a well proven antibacterial that is extensively used in cattle practice,” explains Alvin Cerely, Marbocyl’s product manager. “Marbocyl Solo is exceptionally well placed for applying ‘concentration killing’ or a‘strike action’ strategy as opposed to a ‘long action’ strategy used by other antibiotics. Marbocyl Solo is available as a separate presentation to Marbocyl 10% to avoid confusion, particularly with farmers, on different dosage regimes and withdrawal periods.”
Marbocyl Solo is available now and details have been mailed to all cattle vets in the UK and Ireland. Please contact your Vetoquinol representative or telephone 0800 169 8197 for more details.
The campaign came after the company surveyed livestock farmers in January, February and March this year, and found that cattle producers are struggling to implement changes.
The survey, which received 190 responses, investigated the extent to which beef and dairy producers are aware of methods to sustainably control parasites, how many are following best practice techniques, and what advice and support they need to make a change.
Sioned Timothy, Ruminant Technical Manager at Boehringer Ingelheim Animal Health said: “Reassuringly, 70% of respondents who are the main decision maker indicated that they were either very concerned or a little concerned about wormer resistance on farm. This level of awareness is positive since wormer resistance is on the rise, and the livestock industry must make changes to parasite control if we are to safeguard the effectiveness of wormers."
However, the survey indicated that farmers are not asking professionals such as their vet or SQP for advice on parasite control as much as they could. Only 55% of main decision maker respondents asked their vet for advice on parasite control planning as part of overall herd health planning, and that dropped to 21% for specific parasite control advice.
In addition, only 65% of main decision makers sought advice from an SQP when purchasing worming or fluke products, despite SQPs being qualified to provide parasite control advice at the point of prescription and supply.
Positively, over 60% of main decision maker respondents had already implemented some methods of sustainable parasite control, including quarantining and treating bought-in animals, managing pasture use, and calibrating and testing dosing guns.
However, more than half of the same respondents were aware of but had not implemented several other methods, including weighing or tracking growth rates of youngstock, testing individuals or groups of animals for parasites, and using preventative methods such as vaccinating for lungworm.
Sioned pointed out that nearly 25% of main decision makers had not implemented the calibration or testing of their wormer dosing guns, and a further 12% were not even aware of the practice. She said: “These producers are missing a simple opportunity to ensure that their cattle are dosed correctly. Under-dosing is one of the factors that drives resistance to anthelmintics on farm, and over-dosing increases costs unnecessarily.”
When respondents were asked why they haven’t implemented changes to their parasite control methods, 22% said they did not believe they needed to make changes, 20% don't have the necessary equipment or buildings, 37% said the cost of installing new/better equipment was a barrier, and 32% cited the cost of additional diagnostic tests or treatments.
The survey did highlight some positives. Victoria Hudson, Senior Brand Manager at Boehringer Ingelheim Animal Health, said: “Respondents indicated a good appetite for change provided they could access the appropriate advice and support, including implementing weighing and tracking growth rates of youngstock (53%), testing for parasite burdens in individual animals (52%) and testing for parasite burdens in groups of animals (43%).
“Just over a third of respondents felt they might be able to quarantine and treat bought-in cattle, manage pasture, and use vaccination or other preventative measures. However, only 31% of main decision maker respondents felt they could make the easiest and simplest change: calibrating and testing dosing guns before use.”
One method of sustainable parasite control, targeted selective treatment, where the best performing animals in a group are left untreated, was not well understood or implemented by respondents (30% had implemented, 36% were aware of it but had not implemented, and 33% were not aware of it), and just under 35% felt that even with advice and support they would not be able to implement this method within the next three years.
Victoria said: “Unsurprisingly, over half of main decision maker respondents cited they needed funding to support new equipment/infrastructure to help them make changes to their parasite control practices, but there is a desire for more advice and support.
“Nearly 49% want help in understanding the parasite challenges on their farm, 54% want advice on which changes will most benefit their cattle, and just over 33% want more information on the different types of wormer products.
“However, survey results were conflicting on how farmers would get this advice and support since only 13% wanted more visits from their vet, and 11% from their SQP, despite these professionals being best placed to provide advice at an individual farm level.
“It shows that there is more work to do to help beef and dairy producers make the most effective and sustainable changes to parasite control. This is why we have launched Change One Thing, a campaign to support farmers in understanding and implementing the options available to improve the sustainable control of parasites.”
The campaign is also calling on farm vets to Change One Thing, relating to the information, support and advice that they give livestock farmers.
Victoria said: “It can be difficult for vets to have conversations with farmers about making changes to their parasite control practices, so we urge them to think about changing their approach to discussing the topic, especially if their client/customer has so far resisted making any changes.
“Being inquisitive, and asking questions, can be more effective than ‘telling’, and it’s important that farmers believe in the need to make the change, and that they can practically do it. Even small changes can make a big difference, and testing and trailing strategies tailored to an individual farm will help the farmer to see the benefits for themselves.”
Boehringer says that changes that farmers could make to improve their parasite control in a sustainable way, include:
Resources for farmers, vets and SQPs to Change One Thing are available on the Beat the Parasites website: www.beattheparasites.com/change-one-thing.
Novartis Animal Health UK Ltd has announced the launch of CLiKZiN Pour On for sheep, a short meat withhold period (MWP) product that can be used throughout Spring and Summer for the prevention of blowfly strike in sheep and lambs.
CLiKZiN is a ready-to-use water-based product that protects sheep for eight weeks, and has a meat withhold period of seven days. The product is a line extension of CLiK which offers a longer period of protection at 16 weeks and has a longer withhold period of 40 days. Novartis says that used in conjunction with CLiK, CLiKZiN offers versatile protection throughout the year.
The launch of CLiKZiN comes at the same time that Vetrazin has been reformulated, resulting in a longer meat withhold period for sheep treated with the product.
Thomas Tiley MRCVS from Novartis Animal Health said: "Farmers need reliable protection from the repugnant threat of blowfly strike. CLiKZiN provides eight weeks blowfly prevention together with the trusted performance and safety record associated with CLiK. It also offers the greater flexibility of a seven day meat withhold.
"This makes CLiKZiN ideally suited for a variety of production schedules and stock including lambs for slaughter and pre-shearing ewes."
Blowfly strike can be devastating to sheep, causing severe impact on the welfare of the animal. Within days of a blowfly laying its eggs, clinically normal sheep can be afflicted with flesh eating maggots. This makes prompt and effective treatment critical.
National Sheep Association Chief Executive Peter Morris said: "Fly strike is a terrible burden to the sheep industry both in terms of the welfare of the sheep and economically.
"Having a product available that gives effective prevention against fly strike whilst at the same time having a withdrawal period which does not impinge on the ability of the sheep farmer to market lambs is very welcome. The sheep farmers' armoury against the every day afflictions which affect sheep has been significantly enhanced."
The British Veterinary Association has expressed disappointment, but no surprise, at the Government's decision to reject the multi-faceted approach unanimously recommended by the House of Commons Environment Food and Rural Affairs Committee (EFRACom) to address the spread of Bovine TB within the cattle and badger population.
BVA President Nick Blayney said that the veterinary profession was "deeply concerned about the ongoing lack of disease control and the resulting impact on cattle and badger health and welfare" and that "to date, measures directed at cattle alone have not led to disease control".
While welcoming the commitment to increased funding for research on vaccines, Mr Blayney said: "There is little doubt that any progress is some years down the line and it is hard to see how the Minister can expect either dairy farmers or the veterinary profession to ‘move forward' in tackling the disease when nothing, other than yet another group, albeit under a new name - the Bovine TB Partnership Group - is envisaged for the foreseeable future. Both badgers and cattle are significant animals in the spread of TB as all the science agrees."
James Hutchings, Head of Sales for Bimeda UK, said: "The launch of Tetroxy Vet highlights our ongoing commitment to providing UK veterinarians with a choice of high quality veterinary pharmaceuticals at a fair price."
Bimeda says the benefits of Tetroxy Vet include:
Tetroxy Vet is available in a 100ml pack size.
BSAVA Summit will take place from 16-17 December 2019 at the Royal College of Physicians in London and will involve a series of high-profile keynote speakers and interactive workshops.
The Association says the event will deliver CPD differently to other veterinary meetings, with most sessions run as facilitated workshops to enable delegates to lead and shape discussions.
Confirmed facilitators include RCVS CEO Lizzie Lockett, BEVA President Renate Weller, Director of Clinical Research and Excellence in Practice at VetPartners Rachel Dean and Small Animal Medicine Specialist and Advanced Practitioner in Veterinary Cardiology Dr Kit Sturgess. Each day delegates can choose three out of a total of five workshops. Online forums will be used in the run up to BSAVA Summit to develop ideas and thinking for the workshops before the event.
Day one will focus on ‘The Profession Today’ and topics will include workforce issues, telemedicine, specialism, the future of advanced practitioners and regulation of the profession.
Day two will explore the future of ‘The Profession Tomorrow’ with topics including communication, over-diagnosis, over-treatment and innovation.
On the Monday evening delegates, speakers and facilitators will be able to network at a drinks reception in the library at the Royal College of Physicians.
BSAVA President Sue Paterson said: "We have launched BSAVA Summit to address the rising demand for a space to debate important topics, challenge mindsets and question accepted benchmarks. Following feedback from our members and the profession, Summit will revolutionise veterinary conference norms with a free-flow approach to champion active debate, discussion and reflection.
"There is a growing need to tackle some of the ethical and professional problems that face vets today such as over diagnosis, the role of specialists in practice, and research in practice. Importantly, the format of the discussion forums means that whilst the debate is led by a facilitator, the delegates will drive the agenda to arrive at stimulating and satisfying outcomes. It has been designed to fit with the new outcomes-based approach proposed by the RCVS where veterinary professionals are encouraged to plan their CPD, do their CPD and reflect on what they have learnt.
"The delegates are the key to the event, and Summit should attract people who want to be involved, want to input, want to make a difference and want to help drive the profession forward. I already have people eagerly emailing me wanting news of when the registration goes live.
"Summit aims to help delegates take a hard look at the way they work. Our aim is for each delegate to set themselves personal goals and we will be following up in 3 months to see if they have achieved them."
The BSAVA says that although the Summit is primarily targeted at experienced small animal practitioners, all vets, including equine and large animal practitioners, are welcome to attend.
The full programme will be available and registration will open online on 17th June. BSAVA members will have an opportunity to book advance tickets, with general sale opening two weeks later.
For further information visit www.bsavasummit.com.
1243 farmers took part in the survey, which was held in partnership with the National Beef Association, British Dairying magazine, the relevant farming unions and the four eradication programmes.
Matt Yarnall from Boehringer said: "Reliance on veterinary input for this decision shows how valuable client discussion and guidance is. And further interrogation of the data shows other areas of BVD control where veterinary input could be extremely valuable.
"Too many producers are still holding onto PI animals in the hope they can be reared successfully and too many are making basic mistakes when it comes to herd biosecurity.
"The survey data revealed that 43% of farmers in Wales have identified a PI, but it is hugely concerning that almost half (42%) of these producers would not cull them immediately; these animals will go on to spread virus throughout the herd."
In Northern Ireland, 26 individual producers said they have kept a PI. "However, 20 had to be put down before reaching adulthood or had to be treated for other health conditions," said Matt. "Even in Scotland, with its well-established scheme, a small percentage of farmers claim they would isolate a PI and try to rear to slaughter and it was exactly the same in England."
Similarly, when it came down to the definition of a closed herd, Boehringer reports that there was significant lack of understanding about what this actually means.
Matt said: "Of the 62% of English producers that state they are closed herds, 2% rear calves away, 19% bring bulls in, 2% buy in heifers or cows and 1% purchase fattening stock.
"Obviously, this means they are not truly a closed herd and supports previous years when 23% and 24% of ‘closed herd’ producers in 2018 and 2017 respectively also brought bulls onto the farm.
"Add to this that 10% of these herds do not currently vaccinate so will not be protected against the BVD virus, and it is clear to see how vulnerable they are."
In Wales, 56% of herds were classified as closed, yet 12% still brought bulls on to the farm. Likewise in Northern Ireland, 60% of farms classified their herds as closed but 20% brought bulls on to the unit. The vast majority of Scottish herds also claimed to be closed, yet there were still inconsistencies around buying policy and biosecurity.
Matt said: "A certain lack of awareness about both the BVD Stamp it Out initiative and Gwaredu BVD schemes (43% English and 27% of Welsh producers respectively claimed to have no knowledge of these programmes) could actually be a positive for vets. It could be the perfect opportunity to engage in proactive conversations with clients, covering issues such as testing, PI removal and biosecurity."
Zoetis has announced the availability in the UK and Ireland of Poulvac IBQX, the first specific vaccine against the QX strain of the infectious bronchitis virus.
For the past two years the vaccine has only been available with a special import certificate from the Veterinary Medicines Directorate for use on flocks where the QX virus has been isolated.
According to the company, this variant IB strain has been an increasing problem in European countries over the last 10 years and was first seen in the UK in South-East England in 2007. Since then QX has been isolated from a number of commercial layer and broiler flocks, leading to inferior performance and increased mortality.
James Porritt, Zoetis Poultry Manager for the UK and Ireland said: "Poulvac IB QX adds another protection dimension to our extensive IB vaccine portfolio. The Zoetis IB portfolio offers the widest choice and with Poulvac IBMM + ARK we have the UK's only bivalent live vaccine licensed for day-old use providing a Massachusetts strain and protection against 793/B/91 variant type strains lasting for six weeks post vaccination. Other IB Vaccines include Poulvac H120 and the UK's only other bivalent live vaccine Poulvac IB Primer."
Poulvac IB QX vaccine is based on a live attenuated virus and is administered as a coarse spray to broilers from day-old and to layer pullets or broiler breeders from seven days of age. Protection has been demonstrated by challenge study to last for 63 days after vaccination.
Zoetis says the vaccine is often used on the farm, but can be administered to chicks at the hatchery if adequate controls are in place to avoid spread to other chicks that will be moved to non-QX exposed flocks.
Dr Stuart Andrews, Poultry Veterinary Manager for Zoetis said: "In countering the QX virus strain some existing vaccines have been used to provide a degree of cross-protection. However, it is important to appreciate that Poulvac IB QX is a vaccine homologous to any IB QX field strain and so will provide even better protection.
"Furthermore, our in-house PCR and DNA sequencing service allows us to monitor carefully the field situation to ascertain which IB strains are currently causing field outbreaks and enable us to recommend adaptations to particular vaccination programmes.
"The full approval for the Poulvac vaccine will make it easier and more effective to tackle specific QX infections without having to apply for an import certificate."
Vetoquinol UK has launched Sodium Salicyl 80%, a water soluble, non-steroidal anti-inflammatory drug (NSAID).
Sodium Salicyl 80% contains 800mg of sodium salicylate and is indicated for supportive treatment of pyrexia in acute respiratory disease in calves (of at least two weeks of age). In pigs, Sodium Salicyl 80% is indicated for the treatment of inflammation, in combination with concurrent antibiotic therapy. Vetoquinol says that unlike acetylsalicylic acid (conventional aspirin) which is poorly soluble in water, sodium salicylate is highly water soluble (1 g/ml water), even in the hard water commonly encountered in the UK which makes it ideal for group therapy in any herd.
Sodium Salicyl 80% can be administered orally through the milk replacer or drinking water. Orally administered salicylates are absorbed rapidly and make it easier to treat groups of pigs and calves suffering from stress.
Vetoquinol says it's well known that any focus of pain or discomfort is likely to reduce an animals' feed and water intake, enough to reduce performance and potentially increase the need for the use of antibiotics. NSAID's are ideal for use in times of stress, for example after weaning where they have the ability to reduce inflammation, provide analgesia and reduce pyrexia. Unlike corticosteroids, NSAID's relieve pain and inflammation without the immunosuppressive and metabolic side effects. Stress is a known cause for an acute phase response (inflammation) and viral and bacterial infections are common in this vulnerable period.
Susan Mitchell, Large Animal Product Manager at Vetoquinol said: 'We are delighted to be expanding our large animal range with Sodium Salicyl 80%. We are now able to offer vets and producers a solution for both individual and group situations where an NSAID is required"
Defra has announced plans to form a new Animal Health and Welfare Board for England which will bring experts including farmers, veterinary surgeons, welfare experts and others from outside Government together with the Chief Veterinary Officer and civil servants to make direct policy recommendations on policy affecting the health and welfare of all kept animals such as farm animals, horses and pets.
According to Agriculture Minister Jim Paice, it is the first time that people affected by Government policy on animal health and welfare will make recommendations on those policies directly to Ministers.
Mr Paice said: "This is a completely new way of working. It replaces the old ways, where the people most affected by decisions were kept at arm's length from policy making on those subjects.
"This is about the Big Society not just existing in our communities, but in the heart of Government - helping to put the decisions in the hands of those who are doing the work on the ground.
"We've already seen the success of a partnership between farmers and the Government with the work that's been done on bluetongue - which has seen the disease virtually eradicated in this country."
Final decisions on animal health and welfare policy will remain in the hands of Government Ministers.
The Board will be made up of around 12 members, 5 senior Defra officials including the Chief Veterinary Officer, and 7-8 external members including the chair. The external members will have experience and knowledge of kept and farmed animals, animal and veterinary science, and animal welfare, and could be farmers, veterinarians, animal welfare experts.
The Board and its members will have to represent the views of all stakeholders so will be expected to communicate with them regularly.
The Board's responsibilities will include:
The Board will not be set up as a non departmental public body or arms length body. It will form part of the internal structure of Defra.
Commenting on the announcement, Harvey Locke, President of the British Veterinary Association, said: "The BVA is delighted that both the Advisory Group and Ministers have taken note of the veterinary profession's views in drawing up these plans.
"We said from the outset that genuine responsibility sharing has to be achieved before cost sharing can be discussed and we warned against earlier plans to separate animal health policy from animal welfare policy, as the two are intrinsically linked.
"Animal health and welfare policy issues require expert, scientific input and it will be essential that the new Board includes veterinary representation. We believe that the Board will provide the right mechanism for ensuring decisions are based on sound science.
"The new Board will also have to work closely with the three devolved administrations to ensure that animal health and welfare policies across the UK are joined up and complementary."